ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026
Role of concomitant endomyocardial biopsy in non-ischemic cardiomyopathy with ventricular arrhythmias.
Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn patients with non-ischemic cardiomyopathy (NICM) presenting with ventricular arrhythmias (VAs), the diagnostic yield and clinical significance of routine endomyocardial biopsy (EMB) remain unclear. This study aimed to evaluate the diagnostic utility of EMB with electrophysiological procedures in patients with NICM.
methodsWe enrolled 37 consecutive patients with NICM complicated by VAs who underwent EMB during electrophysiological procedures. Clinical history, imaging data, and genetic testing results were collected, and changes in diagnosis based on EMB findings were assessed.
resultsThe median age was 61 years, and 35 of 37 patients (94.6%) were male. The most common arrhythmia was sustained VT in 27 patients (73.0%), followed by frequent PVCs in 6 (16.2%) and non-sustained VT in 4 (10.8%). Twenty-nine patients (78.4%) underwent catheter ablation, while eight (21.6%) underwent device implantation. EMB identified cardiac amyloidosis in 3 patients (8.1%) via Congo red staining, while the remaining 34 (91.9%) showed nonspecific fibrosis. No complications occurred during EMB. Among the 11 patients (29.7%) who underwent positron emission tomography/computed tomography (PET-CT), six (54.5%) were diagnosed with cardiac sarcoidosis. Genetic testing was performed in 23 patients (62.2%), revealing pathogenic TTN mutations in 2 (8.7%) and an RYR2 mutation (4.3%) consistent with catecholaminergic polymorphic VT. Cardiac MRI was performed in 29 patients (78.4%), with late gadolinium enhancement observed in 2 patients (6.9%) with suspected myocarditis, 1 (3.4%) with suspected sarcoidosis, and 2 (6.9%) with dilated cardiomyopathy. Furthermore, 2 patients (6.9%) showed right ventricular dysfunction with wall motion abnormalities, consistent with arrhythmogenic right ventricular cardiomyopathy.
conclusionEMB can be safely performed during electrophysiological procedures and may aid diagnosis in selected cases, particularly cardiac amyloidosis. However, PET-CT demonstrated greater overall diagnostic utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.